Thread by @ZdenekVrozina

This Long COVID study feels scary for a reason - it hits an immune axis immunologists already know from HIV, HBV, sepsis, and cancer. That makes the result more biologically plausible, not less🧵

https://twitter.com/bagaidr/status/2032611853168423100

A study looked at women with Long COVID with an ME/CFS phenotype using single-cell RNA sequencing of peripheral blood 12 months after acute COVID. It was a detailed look at which immune cells were present, how many there were, and what state they were in.

The main finding.
The immune system did not look like it had simply settled down after infection. It looked chronically remodeled and dysregulated.
There were fewer naive CD4/CD8 T cells, Tregs, MAIT cells, γδ T cells, and NK cells - and more effector T cells, activated B cells, platelets, and low-density neutrophils.

That matters because this is not just a random list of abnormalities. The changes point in the same direction - cells involved in - regulation, reserve capacity, barrier surveillance, and cytotoxic control are reduced, while cells linked to activation, inflammation, and stress signaling are increased.

So this does not look like an immune system that recovered and returned. It looks more like an immune system that stayed stuck in a prolonged state of pressure - activated, imbalanced, and - increasingly costly to maintain.

The T cells also showed signs of chronic activation and exhaustion, while NK cells had a profile consistent with reduced cytotoxic function. That’s important, because it suggests the problem is not just too much immune activity, but also less efficient control of infected or damaged targets.

One of the most striking parts of the paper was the loss of MAIT cells and γδ T cells - fast, innate-like immune cells that matter especially at barrier and mucosal sites. That makes this feel like more than generic inflammation. It points toward disrupted barrier/mucosal immune surveillance as part of the picture.

And that’s where the study gets especially interesting.
The authors propose a role for the Galectin-9/ TIM-3 axis. This is not some obscure pathway. It is a well-known immunology axis tied to T-cell exhaustion, apoptosis, checkpoint signaling, impaired effector function in other serious conditions.

The authors may have identified a real and biologically meaningful axis.
The biggest strength of the paper is that it links a plasma biomarker, a receptor on specific immune cells, and a functional consequence ex vivo. That is much stronger than just saying marker X is up and cell type Y is down.

This is the core logic of the study - there may be a state of ongoing immune pressure, and that pressure may be translated through Galectin-9/TIM-3 into exhaustion, apoptosis, or functional loss in key immune populations - especially MAIT and γδ T cells.

That’s what makes the paper feel coherent. Not just many things are off - it’s that the abnormalities can be read as one connected system. Chronic stimulation - loss of regulatory and reserve cells - persistent effector/inflammatory activity - checkpoint braking and exhaustion - weaker barrier surveillance and cytotoxic cleanup.

The increases in activated B cells, platelets, and low-density neutrophils also fit that same story. This is not only a T-cell problem. It looks more like a system wide immune remodeling, spilling into innate inflammation and thrombo inflammatory biology too.

At the same time, the biggest weakness of the study is still obvious. We do not yet know what sits at the top of the cascade. Is it persistent antigen? Microbial translocation? Tissue DAMPs? Neuroendocrine dysregulation? Some mix of all of the above? The paper hints at a gut/mucosal connection, but does not prove it directly.

That matters, because this mechanism may not be all or nothing. The paper shows a strong clinical version of it in a specific subgroup - women with Long COVID/ME/CFS at 12 months - but the same biology could exist more broadly across Long COVID in milder or less obvious forms. Not everyone has to reach the same depth of dysregulation to be part of the same biological axis.

And the timing is important. These patients looked like this a full year after infection. That does not tell us whether they will worsen, stabilize, or improve - this study is basically a snapshot, not a trajectory. But it does tell us this is not just a short lived post viral afterglow.

Some immune abnormalities in Long COVID may improve over time, but a chronically inflammatory, checkpoint-heavy, cytotoxicity-impaired environment is not something we would consider biologically benign. And if epigenetic remodeling is part of the story too, that raises the possibility of a more durable immune reprogramming, not just a temporary blip.

That’s also why the parallels matter.
HIV and HBV are the best parallels for chronicity and T-cell exhaustion.
Sepsis is the best parallel for the double edged nature of this axis.
Cancer is the best parallel for checkpoint logic.
What makes this Long COVID paper so interesting is that it seems to borrow something from all three.

So yes - this paper is unsettling. Not because it proves hopelessness, but because it suggests that in at least some patients, Long COVID is biologically serious state of immune dysregulation that fits into pathways immunology already associates with major disease.

And that may be the most important takeaway. This is not just about one odd biomarker or one depleted cell type. It is about the possibility that Long COVID becomes a self-reinforcing immune state - one that is activated, exhausted, inflammatory, and not able to fully restore balance. @szupraha @ZdravkoOnline @adamvojtech86

Shahbaz at al., Single-cell analysis reveals immune remodeling of monocytes, NK cells, T cell exhaustion, and Galectin-9–associated depletion of gamma delta and mucosal-associated invariant T cells in Long COVID with ME/CFS. frontiersin.org/journals/immun…